D. Dylewski

Anoikis-resistant subpopulations of human osteosarcoma display significant chemoresistance and are sensitive to targeted epigenetic therapies predicted by expression profiling

K. Dykema, J. Foley, N. Monks, 2015, Journal of Translational Medicine.

Enhanced target gene knockdown by a bifunctional shRNA: a novel approach of RNA interference

D. Rao, N. Senzer, J. Nemunaitis, 2010, Cancer Gene Therapy.

Establishment of genetically diverse patient-derived xenografts of colorectal cancer.

G. Hostetter, J. MacKeigan, Katie R. Martin, 2014, American journal of cancer research.

Using a rhabdomyosarcoma patient‐derived xenograft to examine precision medicine approaches and model acquired resistance

J. Junewick, N. Monks, E. Eugster, 2014, Pediatric blood & cancer.

Melanoma patient derived xenografts acquire distinct Vemurafenib resistance mechanisms.

Karl J. Dykema, K. Dykema, J. MacKeigan, 2015, American journal of cancer research.

Genomic characterization of explant tumorgraft models derived from fresh patient tumor tissue

Yuri Nikolsky, Robin E Everts, Patrick J Richardson, 2012, Journal of Translational Medicine.

In vivo safety and antitumor efficacy of bifunctional small hairpin RNAs specific for the human Stathmin 1 oncoprotein.

H. Frieboes, D. Rao, N. Senzer, 2011, DNA and cell biology.

Anoikis-resistant subpopulations of human osteosarcoma display significant chemoresistance and are sensitive to targeted epigenetic therapies predicted by expression profiling

Karl J. Dykema, K. Dykema, J. Foley, 2015, Journal of Translational Medicine.